|
|
|
|
|
|
|
Sierra Oncology Inc (SRRA)
|
|
2 0.01 (0.5%)
|
04-18 16:00
|
|
Open:
|
2
|
Pre. Close:
|
1.99
|
|
High:
|
2.08
|
Low:
|
1.9402
|
|
Volume:
|
443,395
|
Market Cap:
|
143M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.083 - 2.091
|
2.091 - 2.099
|
|
Low:
|
1.92 - 1.929
|
1.929 - 1.937
|
|
Close:
|
1.986 - 2
|
2 - 2.013
|
|
|
|
Technical analysis (as of: 2018-04-18 4:44:36 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.
|
|
Target:
|
Six months: 2.63 One year: 2.94
|
|
Support:
|
Support1: 1.82 Support2: 1.51
|
|
Resistance:
|
Resistance1:
2.25 Resistance2: 2.52
|
|
Pivot:
|
2.02 
|
|
Moving Averages:
|
MA(5): 1.96 MA(20): 2.06
MA(100): 2.79 MA(250): 2.02
|
|
MACD:
|
MACD(12,26):
-0.13 Signal(12,26,9): -0.14
|
|
%K %D:
|
%K(14,3): 30.64 %D(3): 23.01
|
|
RSI:
|
RSI(14): 40.66
|
|
52-Week:
|
High: 4.09
Low: 1.1 Change(%): 47.1
|
|
Average Vol(K):
|
3-Month: 59357
10-Days 48496
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.SRRA has closed above bottom band by 43.2%. Bollinger Bands are 62.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to SRRA's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-04-17T07:00:00-04:00
Sierra Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARPi to be Presented at the AACR 2018 Annual Meeting
2018-04-06T07:14:53-04:00
Key events next week - healthcare
2018-04-05T17:37:13-04:00
After Hours Gainers / Losers (04/05/2018)
2018-03-27T14:34:23-04:00
Sierra Oncology (SRRA) Presents At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference - Slideshow
2018-03-19T07:00:00-04:00
Sierra Oncology to Present at the Future Leaders in the Biotech Industry Conference in New York
2018-03-14T16:51:00-04:00
Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting
2018-03-08T15:33:44-05:00
Due Diligence Ramp-Up: Sierra Oncology's DNA Damage Gamble
2018-03-02T09:18:14-05:00
Premarket Losers as of 9:05 am (3/2/2018)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
